Skip to main content
Raymond Liu, MD, Oncology, San Francisco, CA

Raymond Liu MD

Gastrointestinal Cancer, Hematologic Oncology, Neuro-Oncology, Complementary and Integrative


Chief of Hematology-Oncology Kaiser Permanente San Francisco Regional Director Cancer Survivorship

Join to View Full Profile
  • 505 Parnassus Ave# M1286San Francisco, CA 94143

  • Phone+1 415-353-1000

Dr. Liu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2005 - 2008
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2001 - 2004
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2026
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Publications & Presentations

PubMed

Press Mentions

  • Blood Clots in Hospitalized Patients Tied to Worse Outcomes
    Blood Clots in Hospitalized Patients Tied to Worse OutcomesNovember 21st, 2022
  • Secure Messaging Increases Oncologists’ Workload, Leads to High Volume of Unreimbursed Care
    Secure Messaging Increases Oncologists’ Workload, Leads to High Volume of Unreimbursed CareAugust 9th, 2023
  • Alcohol Not Likely to Increase Risk of Breast Cancer Recurrence, Study Suggests
    Alcohol Not Likely to Increase Risk of Breast Cancer Recurrence, Study SuggestsAugust 16th, 2023

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: